Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B

ConclusionThis study demonstrates the largely successful transition of 36 patients from SHL to EHL factor products.

Source: Haemophilia - February 5, 2018 Category: Hematology Authors: C. Wang, G. Young Tags: ORIGINAL ARTICLE Source Type: research